Today we celebrate a huge victory for the arthritis community in New Jersey! New Jersey’s Governor, Chris Christie, has signed into law Assembly Bill 2477, a bill that allows biosimilar medications to become available for people with arthritis and other chronic diseases.
AB-2477 creates a pathway for biosimilars to enter the market place, potential for the development of new and innovative medications, and improves access to additional treatment options for people currently relying on biologics. Unlike other generic drug alternatives, biosimilars are developed from proteins in living cells and are highly similar to biologic medications.
The Arthritis Foundation and our team of passionate advocates worked actively and tirelessly toward passage of this bill, leading lobbying efforts of the Foundation’s Advocates, participating in lobbying efforts along with other patient organizations and testifying before the New Jersey legislature. We’re proud to have played a role in the achievement of this life-changing victory for those in New Jersey living with arthritis.